Patents for A61P 19 - Drugs for skeletal disorders (81,981)
07/1995
07/13/1995CA2179986A1 Treatment using arachidonic acid metabolite and particulate formulations
07/12/1995EP0662481A1 Spiro piperidines and homologs promote release of growth hormone
07/12/1995EP0662075A1 Prostaglandin analog for treating osteoporosis
07/06/1995WO1995018141A1 Medicinal composition for bone resorption inhibition and osteogenesis acceleration
07/06/1995WO1995018128A1 Pyrazolopyridine adenosine antagonists
07/06/1995WO1995017904A2 Botulinum toxins for treating various disorders and associated pain
07/06/1995CA2682117A1 The use of the neurotoxic component of a botulinum toxin for the treatment of a facial disease, disorder or condition
07/06/1995CA2589968A1 The use of the neurotoxic component of a botulinum toxin for the treatment of pain associated with muscle activity or contracture
07/06/1995CA2300771A1 Method for treating a mucus secretion
07/06/1995CA2300723A1 Method for treating pain associated with a muscle disorder
07/06/1995CA2300451A1 Method for treating a pyloric valve disease
07/06/1995CA2300433A1 Method for treating a lacrimation disorder
07/06/1995CA2180253A1 Pyrazolopyridine adenosine antagonists
07/04/1995US5430051 Photodynamic diagnosis and therapy of rheumatic diseases
06/1995
06/29/1995WO1995017207A1 Parathyroid hormone formulation
06/29/1995WO1995011013A3 Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women
06/27/1995US5428181 Treatment of bone disorders, osteoporosis
06/27/1995CA2088274C Calcium and trace mineral supplements
06/27/1995CA1336099C Urea based lipoxygenase compounds
06/22/1995WO1995016689A1 IMPROVED PROCESS FOR THE SYNTHESIS OF 2-AMINO-3,5-DIHYDRO-7-SUBSTITUTED-4H-PYRROLO[3,2-d]PYRIMIDIN-4-ONES
06/22/1995WO1995010271A3 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
06/22/1995CA2176040A1 Improved process for the synthesis of 2-amino-3,5-dihydro-7-substituted-4h-pyrrolo[3,2-d]pyrimidin-4-ones
06/21/1995EP0658348A2 Aqueous solution inclusion complexes of benzothiophene compounds with cyclodextrins
06/20/1995US5426122 Methods for reducing blood pressure with dimercaptosuccinic acid (DMSA)
06/15/1995WO1995016035A2 Bmp-12, bmp-13 and tendon-inducing compositions thereof
06/15/1995WO1995016033A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY
06/15/1995WO1995015758A1 Aryl and heteroaryl quinazoline compounds which inhibit csf-1r receptor tyrosine kinase
06/15/1995WO1995007108A3 Formulations for delivery of osteogenic proteins
06/15/1995CA2176825A1 C5a receptor antagonists having substantially no agonist activity
06/15/1995CA2137533A1 Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof
06/14/1995EP0657468A1 Human stromae derived factor
06/14/1995EP0657029A1 Calcium receptor active molecules
06/14/1995EP0656906A1 A novel endothelial cell molecule mediating lymphocyte binding in man
06/14/1995EP0656784A1 Parathyroid hormone fragments and analogs
06/14/1995CN1028866C Method for preparation of methylene bis-phosphonic acid derivatives
06/13/1995US5424293 Phenylimidazolidine derivatives and their use
06/08/1995WO1995015316A1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
06/08/1995CA2604073A1 Poly-.beta.-1.fwdarw.4-n-acetylglucosamine
06/07/1995EP0656348A2 Aceric acid derivatives as medicaments
06/06/1995US5422359 α-aminoketone derivatives
06/01/1995WO1995014778A2 Dna sequence coding for a bmp receptor
06/01/1995WO1995014714A1 Novel integrin-binding peptides
06/01/1995WO1995014696A1 Hindered esters of rapamycin and their use as pharmaceuticals
06/01/1995WO1995014662A1 26,28-methylene-1alpha,25-dihydroxyvitamin d2 compounds
06/01/1995CA2177070A1 Novel integrin-binding peptides
06/01/1995CA2176955A1 Hindered esters of rapamycin and their use as pharmaceuticals
05/1995
05/31/1995EP0655250A1 Compositions of Padina algae or their extracts, and their pharmaceutical, food compositions, or use for the culture of molluscs or arthropodes
05/31/1995EP0542912B1 Calcium and trace mineral supplements
05/30/1995US5420287 1,2 diarylcyclopentenyl compounds for the treatment of inflammation
05/30/1995US5420243 Transforming growth factor
05/30/1995US5420135 Substituted quinoline derivatives
05/30/1995CA2048235C Lowering of blood uric acid levels
05/26/1995WO1995014017A1 Non-peptide tachykinin receptor antagonists
05/26/1995WO1995013803A1 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
05/26/1995WO1995013767A1 Osteogenic product and process
05/26/1995CA2176735A1 Non-peptide tachykinin receptor antagonists
05/26/1995CA2176143A1 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
05/24/1995CN1028528C Salts of optically active 4-hydroxy-8-(3-lower alkoxy-4-phenylsulfinylphenyl) pyrazolo |1,5-a¨-1,3,5-triazines
05/18/1995WO1995013302A1 Cathepsin-l-specific inhibitor polypeptide
05/18/1995CA2151059A1 Cathepsin-l-specific inhibitor polypeptide
05/17/1995EP0652872A1 Optically pure salts of pyridinylmethyl sulfinyl-1h-benzimidazole compounds
05/16/1995US5416117 Cyclopropenone derivatives
05/11/1995WO1995012389A1 Multilamellar liposomal arachidonic acid metabolite formulations
05/11/1995WO1995012388A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
05/11/1995CA2175896A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
05/11/1995CA2175057A1 Multilamellar liposomal arachidonic acid metabolite formulations
05/10/1995EP0651765A1 Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis
05/10/1995EP0651738A1 Natural amino acid derivatives as metalloproteinase inhibitors
05/09/1995US5413997 Triphenylmethane derivatives
05/04/1995WO1995011883A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation
05/04/1995WO1995011684A1 Antagonistic inhibitor against mesenchymal cell growth
05/04/1995WO1995006077A3 Polymeric matrices and their uses in pharmaceutical compositions
05/04/1995CA2170736A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation
05/03/1995EP0650480A1 1-arylsulphonyl, arylcarbonyl and 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines
05/03/1995EP0650361A1 Compositions for the treatment of arthritis containing phosphonates and nsaids
05/03/1995EP0569541B1 Growth factor containing matrix for the treatment of cartilage lesions
05/03/1995CN1102107A Gucixiao capable of removing spur and preparation technology thereof
05/02/1995US5412145 P2'-modified hydroxamic acid collagenase inhibitors
05/02/1995CA1335451C Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
04/1995
04/27/1995WO1995011303A1 Cntf family antagonists
04/27/1995WO1995011221A1 Calcium receptor-active arylalkyl amines
04/27/1995WO1995011029A1 Combination of bisphosphonates and growth hormone secretagogues
04/27/1995WO1995011013A2 Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women
04/27/1995CA2173333A1 Combination of bisphosphonates and growth hormone secretagogues
04/26/1995EP0649309A1 Use of particles of a biocompatible, bioabsorbable calcium salt as active principle in the preparation of a medicament for local treatment of bone demineralizing diseases
04/26/1995CN1101915A New 19-nor steroids having a phenoxyalkylsulphonamide or phenoxyalkylsulphonylurea chain in position llbeta, preparation process and intermediates, use as medicaments and pharmaceutical compositions..
04/25/1995US5409911 Prostaglandin analog for treating osteoporosis
04/20/1995WO1995010518A1 ALKOXY ALKYL CARBAMATES FROM IMIDAZO (1,2-a)PYRIDINES
04/20/1995WO1995010271A2 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
04/19/1995EP0648120A1 Use of phosphonates for the treatment of osteoporosis
04/19/1995CN1101549A Herbal medicine health cosmetic series products and its preparing method
04/19/1995CN1028237C Composition for stimulating chondrocytes and osteoblasts, method for its production
04/13/1995WO1995007934A3 Il8 inhibitors
04/13/1995WO1995000501A3 Phenyl heterocycles as cyclooxygenase-2 inhibitors
04/12/1995EP0647266A1 D-enzyme compositions and methods of their use
04/11/1995US5405757 Synthesis of human procollagens and collagens in recombinant DNA systems
04/11/1995US5405620 Pharmaceutical composition for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or tumorous origin
04/05/1995EP0646578A1 Phenyl carboxamide-isoxazole-derivatives and salts, process for their preparation, their use as pharmaceuticals, and pharmaceutical compositions containing them
04/05/1995EP0646119A1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque
04/05/1995CN1100939A Lianhuangsong pill and capsule and its preparation method